| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma
|
Belogurova, Margarita B.
|
|
2016
|
79 |
1 |
p. 155-164
|
artikel
|
| 2 |
A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors
|
Spicer, James
|
|
2016
|
79 |
1 |
p. 17-27
|
artikel
|
| 3 |
A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors
|
Doi, Toshihiko
|
|
2016
|
79 |
1 |
p. 89-98
|
artikel
|
| 4 |
Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma
|
Lee, Ji Young
|
|
2016
|
79 |
1 |
p. 173-180
|
artikel
|
| 5 |
Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma
|
Lee, Sung Won
|
|
2016
|
79 |
1 |
p. 81-88
|
artikel
|
| 6 |
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor
|
Yoo, Changhoon
|
|
2016
|
79 |
1 |
p. 139-146
|
artikel
|
| 7 |
Efficacy and safety of nab-paclitaxel in patients with previously treated metastatic colorectal cancer: a phase II COLO-001 trial
|
Ducreux, Michel
|
|
2016
|
79 |
1 |
p. 9-16
|
artikel
|
| 8 |
Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration
|
Sy, S. Kenneth
|
|
2016
|
79 |
1 |
p. 57-67
|
artikel
|
| 9 |
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium
|
Balis, Frank M.
|
|
2016
|
79 |
1 |
p. 181-187
|
artikel
|
| 10 |
LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer
|
Takahashi, Shunji
|
|
2016
|
79 |
1 |
p. 131-138
|
artikel
|
| 11 |
Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma
|
Zhang, Hui
|
|
2016
|
79 |
1 |
p. 49-55
|
artikel
|
| 12 |
Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma
|
Zhang, Hui
|
|
|
79 |
1 |
p. 49-55
|
artikel
|
| 13 |
Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure
|
Dao, Kim
|
|
2016
|
79 |
1 |
p. 215-218
|
artikel
|
| 14 |
Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer
|
Yoshino, Takayuki
|
|
2016
|
79 |
1 |
p. 107-116
|
artikel
|
| 15 |
Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104)
|
Satake, Hironaga
|
|
2016
|
79 |
1 |
p. 147-153
|
artikel
|
| 16 |
Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
|
He, Ming-ming
|
|
2016
|
79 |
1 |
p. 69-79
|
artikel
|
| 17 |
Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer
|
Kaira, Kyoichi
|
|
2016
|
79 |
1 |
p. 165-171
|
artikel
|
| 18 |
Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies
|
Kunos, Charles A.
|
|
2016
|
79 |
1 |
p. 201-207
|
artikel
|
| 19 |
Population pharmacokinetics of lenalidomide in multiple myeloma patients
|
Guglieri-López, Beatriz
|
|
2016
|
79 |
1 |
p. 189-200
|
artikel
|
| 20 |
Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study)
|
Nakamura, Masato
|
|
2016
|
79 |
1 |
p. 29-36
|
artikel
|
| 21 |
Rituximab to treat gemcitabine-induced hemolytic–uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review
|
Ritchie, Georgia E.
|
|
2016
|
79 |
1 |
p. 1-7
|
artikel
|
| 22 |
Successful afatinib treatment of advanced non-small-cell lung cancer patients undergoing hemodialysis
|
Imai, Hisao
|
|
2016
|
79 |
1 |
p. 209-213
|
artikel
|
| 23 |
Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact
|
Murakami, Yoshiaki
|
|
2016
|
79 |
1 |
p. 37-47
|
artikel
|
| 24 |
Synergistic disruption of ERα/HER2 crosstalk by endoxifen and lapatinib in breast cancer cells
|
Chan, James Chun Yip
|
|
2016
|
79 |
1 |
p. 117-130
|
artikel
|
| 25 |
The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas
|
Kim, Young Saing
|
|
2016
|
79 |
1 |
p. 99-106
|
artikel
|
Tijdschrift beschrijving